GlassScriptPhysician profile
Stephen Nelson
NPI 1194161604
$5,815.76
in general payments reported to CMS, 2019-2025
17 companies · $1,142 in 2025
The $1,142 reported for 2025 was more than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,605 · 2020: $193 · 2021: $545 · 2022: $208 · 2023: $630 · 2024: $493 · 2025: $1,142.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,265.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,265.18 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $2,814.85 | 2019-2025 | Mako, Triathlon, Insignia |
| Encore Medical, LP | $1,609.25 | 2019 | |
| Smith+Nephew, INC. | $250.77 | 2019-2024 | Lens 4k, N/A, 660hd-E Image Management System |
| Depuy Synthes Sales INC. | $197.74 | 2019-2025 | Orthovisc, Monovisc, Peak |
| Davol INC. | $158.60 | 2022 | |
| Zimmer Biomet Holdings, INC. | $144.19 | 2024 | |
| Pacira Therapeutics, INC. | $123.05 | 2019-2021 | |
| Medical Device Business Services, INC. | $91.43 | 2019 | |
| Nextstep Arthropedix, LLC | $84.50 | 2021 | |
| Horizon Therapeutics Plc | $70.39 | 2021-2022 | |
| Ferring Pharmaceuticals INC. | $64.57 | 2024-2025 | Euflexxa |
| Omnilife Science, INC | $61.76 | 2023 | Omnibotics 3.0 |
| Vertex Pharmaceuticals Incorporated | $55.21 | 2024-2025 | |
| Lightforce Orthodontics, INC. | $34.23 | 2023 | |
| Medacta USA, INC. | $19.59 | 2020 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bioventus LLC | $18.98 | 2022 | |
| Biodelivery Sciences International, INC. | $16.65 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Stephen Nelson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.